Our team of multi-disciplinary scientists and engineers have once again improved on the NuTec Slide. This was only made possible by building on past insights and proprietary know-how. The latest version of NuTec Slides show improved reproducibility and sample discernment, while being able to handle a wider range of sample intensities. The Gen 5 NuTec Slide will be used for commercial applications in the U.S.
‘Why OpsisDx?’ is a blog series written by people part of the Entopsis-verse and offers insights into potential OpsisDxTM addressable medical conditions.
Cancer is probably one of the most apprehended conditions in the modern world. Raising to the spotlight in the 20th century and becoming increasingly prevalent while also acquiring higher incidence rates, it is no surprise why this condition has spiked scientists’ interest as well as fueled funding on diagnostics and therapeutics (1). As of 2018, there were 18mil new cases of cancer worldwide, and, around 430K deaths caused by cancer in the pancreas alone (2).
As illustrated by
Great article on our team’s efforts to detect cancer early and thereby improve healthcare outcomes, while reducing costs.
Full article:
https://www.360dx.com/cancer/entopsis-targets-prostate-cancer-screening-multi-analyte-profiling-tech
Want a PDF copy of the article? e-mail us at info@entopsis.com
